Eurocann International plc is an investment vehicle listed on the AQSE Growth Market Exchange, which is focused on the medicinal cannabis market. The Company’s remit is to invest in companies, projects, or products that are either progressing medicinal or therapeutic cannabis research, or that are in the process of product development, and which require funding so as to progress such development through to commercialisation.
The Company anticipates investing primarily in private businesses and projects, including, but not limited to nutraceuticals, dietary supplements, cosmetic products that contain cannabis or hemp, or the cultivation of cannabis and its derivative strains.
Investments in CBD oil for dietary and Medicinal use.
Investments into hemp derivative products.
The cultivation of cannabis and its derivative strains.